Across TCGA pan-cancer cohorts, NUTM2D Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NUTM2D data layer compared with 25 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher NUTM2D Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NUTM2D expression acts as an unfavorable survival marker.

SKCM and BLCA are the cancer types where NUTM2D Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Median	All	0.238	0.784	<.001	15	view →
BLCA	DFS	Median	All	0.096	0.615	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: NUTM2D tumor-vs-normal RNA expression · all NUTM2D data types